Use of adenoviral vectors with a minimal cytomegalovirus promoter

被引：0
|
作者：
Ferrer-Martínez, A [1 ]
García-Martínez, C [1 ]
Gómez-Foix, AM [1 ]
机构：
[1] Univ Barcelona, Dept Bioquim & Biol Mol, E-08028 Barcelona, Catalonia, Spain
来源：
BIOTECHNIQUES | 2003年 / 34卷 / 03期
关键词：
D O I：
10.2144/03343dd02
中图分类号：
Q5 [生物化学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：600 / 602
页数：3
相关论文
共 50 条
  • [21] Targeted adenoviral vectors
    E Vigne
    A Brie
    K Martin
    A Gillardeaux
    P Opolon
    M Perricaudet
    M Latta-Mahieu
    JF Dedieu
    P Yeh
    Arthritis Research & Therapy, 3 (Suppl 1)
  • [22] Use of chimeric adenoviral vectors to assess capsid neutralization determinants
    Roy, S
    Clawson, DS
    Calcedo, R
    Lebherz, C
    Sanmiguel, J
    Wu, D
    Wilson, JM
    VIROLOGY, 2005, 333 (02) : 207 - 214
  • [23] Adenoviral vectors: not to be sneezed at
    Searle, PF
    Mautner, V
    GENE THERAPY, 1998, 5 (06) : 725 - 727
  • [24] Circumventing Antivector Immunity: Potential Use of Nonhuman Adenoviral Vectors
    Lopez-Gordo, Estrella
    Podgorski, Iva I.
    Downes, Nicholas
    Alemany, Ramon
    HUMAN GENE THERAPY, 2014, 25 (04) : 285 - 300
  • [25] Construction of adenoviral vectors
    Alan R. Davis
    Nelson A. Wivel
    Joseph L. Palladino
    Luan Tao
    James M. Wilson
    Molecular Biotechnology, 2001, 18 : 63 - 70
  • [26] Use of chimeric adenoviral vectors to assess capsid neutralization determinants
    Roy, S
    Clawson, D
    Lebherz, C
    Calcedo, R
    Sanmiguel, J
    Wu, D
    Wilson, JM
    MOLECULAR THERAPY, 2004, 9 : S50 - S50
  • [27] Targeted adenoviral vectors
    Vigne, E.
    Brie, A.
    Martin, K.
    Gillardeaux, A.
    Opolon, P.
    Perricaudet, M.
    Latta-Mahieu, M.
    Dedieu, J. F.
    Yeh, P.
    ARTHRITIS RESEARCH & THERAPY, 2001, 3
  • [28] The Controlled Transgene Expression in Oncolytic Adenoviral Vectors with Major Late Promoter for Therapy of Cancer
    Jiang, Wei
    Cai, Rong
    Yang, Guanghua
    Chen, Kai
    Chen, Yu
    Liu, Xinyuan
    Qian, Cheng
    MOLECULAR THERAPY, 2006, 13 : S251 - S251
  • [29] Cyclooxygenase-2 promoter for tumour-specific targeting of adenoviral vectors to melanoma
    Nettelbeck, DM
    Rivera, AA
    Davydova, J
    Dieckmann, D
    Yamamoto, M
    Curiel, DT
    MELANOMA RESEARCH, 2003, 13 (03) : 287 - 292
  • [30] Conditionally replicating adenoviral vectors with E1A under a GLIA specific promoter
    de Leeuw, B
    Hoeben, R
    Brenner, M
    Smitt, PAES
    NEUROLOGY, 2004, 62 (07) : A471 - A472
12345